Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2013
This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSC markets as they are evolving rapidly.
In this report, we focus upon technical and business trends in these spaces as they are fast evolving. CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis. Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes.
Select Biosciences has performed worldwide market tracking wherein we’ve analyzed research trends in the study of CTCs and CSCs. Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilized for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research activity vis-a-vis CTCs and CSCs are described in this dataset derived from worldwide pools of researchers in November and December 2012—therefore these data reflect an up-to-date market landscape.
Select Biosciences has also performed extensive analysis of the various clinical trials where CTCs are being enumerated and analyzed. These clinical data set the trajectory of the clinical utility of CTCs.
This data-driven characterization of the CTCs and CSCs landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in Microsoft PowerPoint format.
Extensive Technical and Market Analyses Presented in this Report
Molecular Characterization of CTCs and CSCs
Technologies for Studying CTCs
CTC Analysis Workflow
Enrichment and Analysis Methodologies
Details of Selected Approaches for CTC Enumeration and Analysis
Name of Company/Institution
Microfluidics-based Approaches
Imaging-based Approaches
CTC and CSC Research Market Landscape
Bottom-up Market Survey Data: Qualitative and Quantitative Market Analysis
Product Vendors and their Penetrance into the Research Market
Methodologies for Studying CTCs and CSCs
Markers for Characterizing CTCs and CSCs
Downstream Analyses on Captured CTCs
CTC Quantitative Market Metrics
Revenues from Clinical Utilization—Market Size, Market Forecast, Growth Rate
Analysis of Clinical Utility of CTCs
Evidence for Biomarker Utility of CTCs
CTC and CSC Clinical Trials Analysis
In this report, we focus upon technical and business trends in these spaces as they are fast evolving. CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis. Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes.
Select Biosciences has performed worldwide market tracking wherein we’ve analyzed research trends in the study of CTCs and CSCs. Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilized for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research activity vis-a-vis CTCs and CSCs are described in this dataset derived from worldwide pools of researchers in November and December 2012—therefore these data reflect an up-to-date market landscape.
Select Biosciences has also performed extensive analysis of the various clinical trials where CTCs are being enumerated and analyzed. These clinical data set the trajectory of the clinical utility of CTCs.
This data-driven characterization of the CTCs and CSCs landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in Microsoft PowerPoint format.
Extensive Technical and Market Analyses Presented in this Report
Molecular Characterization of CTCs and CSCs
Technologies for Studying CTCs
CTC Analysis Workflow
Enrichment and Analysis Methodologies
Details of Selected Approaches for CTC Enumeration and Analysis
Name of Company/Institution
Microfluidics-based Approaches
Imaging-based Approaches
CTC and CSC Research Market Landscape
Bottom-up Market Survey Data: Qualitative and Quantitative Market Analysis
Product Vendors and their Penetrance into the Research Market
Methodologies for Studying CTCs and CSCs
Markers for Characterizing CTCs and CSCs
Downstream Analyses on Captured CTCs
CTC Quantitative Market Metrics
Revenues from Clinical Utilization—Market Size, Market Forecast, Growth Rate
Analysis of Clinical Utility of CTCs
Evidence for Biomarker Utility of CTCs
CTC and CSC Clinical Trials Analysis
CHAPTER I. CELLULAR THERAPEUTICS MARKET LANDSCAPE
Stem Cell Market Segmentation and Industry Structure
Quantitative Trends in the Cellular Therapy and Regenerative Medicine Marketplace
Regenerative Medicine and Stem Cell Research Activity in the US
Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
Breakout of Spending by Product Platforms in Various Spaces
Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
Autologous vs. Allogeneic Cellular Therapy: Industry SWOT Market Timeline
Adult Stem Cell Therapy Quantitative Market Forecast
Stem Cell Research Workflow and Product Development Value Chain
Quantitative Scale of Cellular Therapy Market Opportunities in Various Disease Classes
Cellular Therapy Product Pipeline
Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic Areas Addressed, Geography
Companies and Marketed Cellular Therapy Products Currently
CHAPTER II. CORD BLOOD MARKET LANDSCAPE
The HSCT Landscape
HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
Indications for HSCTs in North America: Disease Classes Addressed, Age
of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
Cost Analyses of HSCTs in the EU vs. US Markets
Reimbursement Codes and Reimbursed Amounts for Various Procedures
Associated with HSCTs
The Emerging and Evolving Cord Blood Landscape
Cord Blood Banking Quantitative Market Metrics
Growth of BM, PBL, and CB Units Worldwide in Public Banks and
Registries, Segmented by Country
Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
Cord Blood TNCs Landscape and Trends
Cord Blood Banking Cost Breakouts
EU and US Cord Blood Transplantation Detailed Cost Breakouts
CHAPTER III. STEM CELL OPPORTUNITIES AND FUNDING SOURCES IN SOME OF THE TOP MARKETS ACROSS THE EUROPEAN UNION THE EUROPEAN UNION
APPENDIX I. SELECTED MARKET OPPORTUNITIES IN THE CELLULAR THERAPEUTICS SPACE
APPENDIX II. STEM CELL PUBLICATIONS HOTSPOT MAPPING ANALYSIS
APPENDIX III. RESEARCH METHODOLOGY
Stem Cell Market Segmentation and Industry Structure
Quantitative Trends in the Cellular Therapy and Regenerative Medicine Marketplace
Regenerative Medicine and Stem Cell Research Activity in the US
Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
Breakout of Spending by Product Platforms in Various Spaces
Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
Autologous vs. Allogeneic Cellular Therapy: Industry SWOT Market Timeline
Adult Stem Cell Therapy Quantitative Market Forecast
Stem Cell Research Workflow and Product Development Value Chain
Quantitative Scale of Cellular Therapy Market Opportunities in Various Disease Classes
Cellular Therapy Product Pipeline
Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic Areas Addressed, Geography
Companies and Marketed Cellular Therapy Products Currently
CHAPTER II. CORD BLOOD MARKET LANDSCAPE
The HSCT Landscape
HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
Indications for HSCTs in North America: Disease Classes Addressed, Age
of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
Cost Analyses of HSCTs in the EU vs. US Markets
Reimbursement Codes and Reimbursed Amounts for Various Procedures
Associated with HSCTs
The Emerging and Evolving Cord Blood Landscape
Cord Blood Banking Quantitative Market Metrics
Growth of BM, PBL, and CB Units Worldwide in Public Banks and
Registries, Segmented by Country
Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
Cord Blood TNCs Landscape and Trends
Cord Blood Banking Cost Breakouts
EU and US Cord Blood Transplantation Detailed Cost Breakouts
CHAPTER III. STEM CELL OPPORTUNITIES AND FUNDING SOURCES IN SOME OF THE TOP MARKETS ACROSS THE EUROPEAN UNION THE EUROPEAN UNION
APPENDIX I. SELECTED MARKET OPPORTUNITIES IN THE CELLULAR THERAPEUTICS SPACE
APPENDIX II. STEM CELL PUBLICATIONS HOTSPOT MAPPING ANALYSIS
APPENDIX III. RESEARCH METHODOLOGY
